Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Jul;8(7):1398-405.
doi: 10.21037/jtd.2016.05.69.

Coronary stent thrombosis: what have we learned?

Carlos Collet  1 , Yohei Sotomi  1 , Rafael Cavalcante  2 , Pannipa Suwannasom  3 , Erhan Tenekecioglu  2 , Yoshinobu Onuma  2 , Patrick W Serruys  4
Affiliations
Comment

Coronary stent thrombosis: what have we learned?

Carlos Collet et al. J Thorac Dis. 2016 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Dr. Y. Sotomi is a consultant of GOODMAN and has received a grant from Fukuda Memorial Foundation for Medical Research and SUNRISE lab. Dr. P. W. Serruys and Y. Onuma are a members of the Advisory Board for Abbott Vascular. The other authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Optical coherence tomography images of stent thrombosis cases. Representative examples of stent thrombosis underlying mechanisms explored by optical coherence tomography imaging after optimal thrombus resorption in acute stent thrombosis with edge dissection (A); sub-acute stent thrombosis with major stent malapposition (B); late stent thrombosis with isolated uncovered struts (C); very late stent thrombosis with neoatherosclerosis lesion (D); ruptured neoatherosclerotic lesion (E and F); major stent underexpansion with stent area and reference lumen area measurements (G); coronary evaginations related to underlying positive remodeling (H). Reproduced with permission of Souteyrand et al.
Figure 2
Figure 2
Simulation of blood flow in the vicinity of stents struts. (A) Path-lines generated by 1 µm fluorescent particles in the vicinity of stent struts of increasing size (50 to 150 µm) demonstrate the formation of a range of recirculation zones by different geometries; (B) representative images of fibrin deposition near stent struts; (C) distal and proximal fibrin deposition near the stent strut of disturbed flow (DF) and undisturbed flow (UF); (D) WSS distribution for UF (grey) and DF (black) waveforms in the artery model. Reproduced with permission of Jimenez et al.
See this image and copyright information in PMC

Comment on

References

    1. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23. 10.1056/NEJMoa035071 - DOI - PubMed
    1. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-31. 10.1056/NEJMoa032441 - DOI - PubMed
    1. Palmerini T, Biondi-Zoccai G, Della Riva D, et al. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. J Am Coll Cardiol 2014;63:299-307. 10.1016/j.jacc.2013.09.061 - DOI - PubMed
    1. Palmerini T, Benedetto U, Biondi-Zoccai G, et al. Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis. J Am Coll Cardiol 2015;65:2496-507. 10.1016/j.jacc.2015.04.017 - DOI - PubMed
    1. Ahn JM, Kang SJ, Yoon SH, et al. Meta-analysis of outcomes after intravascular ultrasound-guided versus angiography-guided drug-eluting stent implantation in 26,503 patients enrolled in three randomized trials and 14 observational studies. Am J Cardiol 2014;113:1338-47. 10.1016/j.amjcard.2013.12.043 - DOI - PubMed

LinkOut - more resources